Chronic Graft-Versus-Host Disease (cGVHD) following Unrelated Donor Hematopoietic Stem Cell Transplantation (HSCT): Higher Response Rate In Recipients of Unrelated Donor (URD) Umbilical Cord Blood (UCB)

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 10, 2007, Pages 1145-1152

  Arora, Mukta ^a   Nagaraj, Sriharsha ^a   Wagner, John E ^a   Barker, Juliet N ^a   Brunstein, Claudio G ^a   Burns, Linda J ^a   DeFor, Todd E ^a   McMillan, Margaret L ^a   Miller, Jeffrey S ^a   Weisdorf, Daniel J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

cGVHD; Hematopoietic stem cell transplantation; Umbilical cord blood transplant

Indexed keywords

AZATHIOPRINE; BUSULFAN; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; MEPREDNISONE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THALIDOMIDE; THYMOCYTE ANTIBODY; TRIAMCINOLONE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; HUMAN CELL; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; RELAPSE; REMISSION; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; CHRONIC DISEASE; COHORT STUDIES; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MINNESOTA; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548695657     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.06.004     Document Type: Article

References (31)

1. Socie G., Stone J.V., Wingard J.R., et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 341 (1999) 14-21
2. Ochs L.A., Miller W.J., Filipovich A.H., et al. Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation. Bone Marrow Transplant 13 (1994) 455-460
3. Storb R., Prentice R.L., Sullivan K.M., et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 98 (1983) 461-466
4. Bostrom L., Ringden O., Jacobsen N., et al. A European multicenter study of chronic graft-versus-host disease. The role of cytomegalovirus serology in recipients and donors-acute graft-versus-host disease, and splenectomy. Transplantation 49 (1990) 1100-1105
5. Atkinson K., Horowitz M.M., Gale R.P., et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 75 (1990) 2459-2464
6. Ringden O., Paulin T., Lonnqvist B., et al. An analysis of factors predisposing to chronic graft-versus-host disease. Exp Hematol 13 (1985) 1062-1067
7. Carlens S., Ringden O., Remberger M., et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 22 (1998) 755-761
8. Przepiorka D., Anderlini P., Saliba R., et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 98 (2001) 1695-1700
9. Storek J., Gooley T., Siadak M., et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft versus-host disease. Blood 90 (1997) 4705-4709
10. Anderson D., DeFor T., Burns L., et al. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections. Biol Blood Marrow Transplant 9 (2003) 52-59
11. Cutler C., Giri S., Jeyapalan S., Paniagua D., Viswanathan A., and Antin J.H. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 19 (2001) 3685-3691
12. Pavletic S.Z., Smith L.M., Bishop M.R., et al. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation. Am J Hematol 78 (2005) 265-274
13. Remberger M., Kumlien G., Aschan J., et al. Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 8 (2002) 674-682
14. Pavletic S.Z., Carter S.L., Kernan N.A., et al. Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation. Blood 106 (2005) 3308-3313
15. Sullivan K.M., Shulman H.M., Storb R., et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 57 (1981) 267-276
16. Akpek G., Lee S.J., Flowers M.E., and Pavletic S.Z. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 102 (2003) 802-809
17. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 69 (1980) 204-217
18. Arora M., Burns L.J., Davies S.M., et al. Chronic graft versus host disease: a prospective cohort study. Biol Blood Marrow Transplant 9 (2003) 38-45
19. Sullivan K.M., Witherspoon R.P., Storb R., et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood 72 (1988) 546-554
20. Wingard J.R., Piantadosi S., Vogelsang G.B., et al. Predictors of death from chronic graft-versus-host-disease after bone marrow transplantation. Blood 74 (1989) 1428-1435
21. Lee S.J., Klein J.P., Barret A.J., et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 100 (2002) 406-414
22. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351 (2004) 2265-2275
23. Barker J.N., Davies S.M., DeFor T., Ramsay N.K., Weisdorf D.J., and Wagner J.E. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 97 (2001) 2957-2961
24. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11 (2005) 945-956
25. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457
26. Cox D.R. Regression models and life-tables. J R Stat Soc (B) 34 (1972) 187
27. Lin D.Y. Non parametric inference for cumulative incidence functions in competing risk studies. Stat Med 16 (1997) 901-910
28. Arora M., Wagner J.E., Davies S.M., et al. Randomized clinical trial of Thalidomide, cyclosporine and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft versus host disease. Biol Blood Marrow Transplant 7 (2001) 265-273
29. Akpek G., Zahurak M.L., Piantadosi S., et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood 97 (2001) 1219-1226
30. Stewart B.L., Storer B., Storek J., et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 104 (2004) 3501-3506
31. Koc S., Leisenring W., Flowers M.E., et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 100 (2002) 48-51